secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2025-07-07T23:59:59+00:00
Accession:  0001104659-25-065981
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Collegium Pharmaceutical authorizes up to $150M share repurchase program through Dec 2026
--------------------------------------------------------------------------------

- Board authorized $150M share repurchase program, valid through Dec 31, 2026.
- Repurchases will be executed on open market based on market conditions and share price.
- Program funded by existing cash on hand; timing and amount of purchases discretionary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465925065981/0001104659-25-065981-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465925065981/tm2519449d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-065981

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer